Review: taking Zantac 150 and Tobramycin sulfate together


Summary

Drug interactions are reported among people who take Zantac 150 and Tobramycin sulfate together. This review analyzes the effectiveness and drug interactions between Zantac 150 and Tobramycin sulfate. It is created by eHealthMe based on reports of 118 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zantac 150

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Zantac 150 4,243 users)

Tobramycin Sulfate

Tobramycin sulfate has active ingredients of tobramycin sulfate. It is often used in infection. (latest outcomes from Tobramycin sulfate 291 users)

On Sep, 27, 2016

118 people who take Zantac 150, Tobramycin Sulfate are studied.


Number of reports submitted per year:

Zantac 150 and Tobramycin sulfate drug interactions.

Most common drug interactions over time *:

< 1 month:
  • neutropenia
  • malaise
  • febrile neutropenia
  • diarrhoea
  • ileus
  • multi-organ failure
  • vomiting
  • anxiety
  • depression
  • drug ineffective
2 - 5 years:
  • colostomy
not specified:
  • pyrexia
  • atrial fibrillation
  • acute generalised exanthematous pustulosis
  • haemoglobin decreased
  • multi-organ failure
  • febrile neutropenia
  • pseudomonas infection
  • oral candidiasis
  • blood culture positive
  • haematocrit decreased

Most common drug interactions by gender *:

female:
  • neutropenia
  • febrile neutropenia
  • pyrexia
  • cough
  • nausea
  • pseudomonas infection
  • accidental overdose (therapeutic agent)
  • atrial fibrillation
  • blister
  • c-reactive protein increased
male:
  • febrile neutropenia
  • multi-organ failure
  • acute generalised exanthematous pustulosis
  • atrial fibrillation
  • back pain
  • haemoglobin decreased
  • pneumonia
  • weight decreased
  • abdominal discomfort
  • blood culture positive

Most common drug interactions by age *:

0-1:
  • catheter sepsis
  • enterococcal sepsis
  • drug ineffective
  • extravasation
  • haemodynamic instability
  • infusion site pain
  • infusion site swelling
  • intraventricular haemorrhage
  • intraventricular haemorrhage neonatal
  • neonatal disorder
2-9:
  • ammonia increased
  • death
  • depressed level of consciousness
  • eyelid ptosis
  • seizure
10-19:
  • blister
  • corneal erosion
  • multi-organ failure
  • pyrexia
  • stevens johnson syndrome
  • oral mucosal blistering
  • epidermal necrolysis
  • rash maculo-papular
  • acute circulatory failure
  • arthralgia
20-29:
  • accidental overdose (therapeutic agent)
  • c-reactive protein increased
  • graft rejection
  • pyrexia
  • tachypnoea
  • bronchial obstruction
  • bronchoscopy abnormal
  • nausea
  • pulmonary vascular resistance abnormality
  • blood magnesium decreased
30-39:
  • diarrhoea
  • febrile neutropenia
  • ileus
  • multi-organ failure
  • vomiting
  • anxiety
  • depression
  • drug ineffective
  • renal failure acute
  • acute lymphocytic leukaemia
40-49:
  • neutropenia
  • febrile neutropenia
  • immunosuppressant drug level increased
  • pancreatitis acute
  • splenomegaly
  • abdominal discomfort
  • abdominal distension
  • acute respiratory distress syndrome
  • agitation
  • anasarca
50-59:
  • neutropenia
  • febrile neutropenia
  • device related infection
  • erythema
  • laryngospasm
  • rash macular
  • rigors
  • toxic epidermal necrolysis
60+:
  • atrial fibrillation
  • acute generalised exanthematous pustulosis
  • haemoglobin decreased
  • febrile neutropenia
  • pseudomonas infection
  • oral candidiasis
  • blood culture positive
  • haematocrit decreased
  • streptococcal infection
  • unresponsive to stimuli

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zantac 150 and Tobramycin sulfate?

Can you answer these questions?

More questions for: Zantac 150, Tobramycin sulfate

You may be interested in these reviews

More reviews for: Zantac 150, Tobramycin sulfate

On eHealthMe, Zantac 150 (ranitidine hydrochloride) is often used to treat indigestion. Tobramycin sulfate (tobramycin sulfate) is often used to treat infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.